台股 » 個股 » 佳醫 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

佳醫

(4104)
可現股當沖
  • 股價
    88.3
  • 漲跌
    ▲0.2
  • 漲幅
    +0.23%
  • 成交量
    99
  • 產業
    上市 生技醫療類股▲0.96%
  • 331人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
佳醫 (4104)籌碼相關-永豐金-桃盛 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw05/0405/1806/0106/1406/2807/1207/2608/1008/2409/0609/2010/0410/1811/0211/1611/3012/1412/2801/1002/0402/1602/2603/1003/2004/0104/038486889092May '24Jul '24Sep '24Nov '24Jan '25Mar '2560d90dAll

永豐金-桃盛 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/04/0100.000.388.3088.10-0.3104-0.29%
2025/03/31087.9000.0087.7001020.03%
2025/03/28089.0000.0088.800980.02%
2025/03/27089.5000.0089.400970.02%
2025/03/26089.8000.0089.800980.03%
2025/03/24090.00190.3090.10-197-0.98%
2025/03/21090.0000.0090.400970.03%
2025/03/14088.6000.0088.400910.03%
2025/03/110.389.0000.0089.200.3890.34%
2025/03/1000.001.189.3089.50-1.186-1.21%
2025/02/2400.00287.2587.40-274-2.69%
2025/02/06286.3000.0085.602762.62%
2025/02/05085.9000.0085.800750.01%
2024/12/17186.3000.0086.301741.34%
2024/11/190.586.4000.0086.500.5820.60%
2024/10/29287.5000.0087.1021051.89%
2024/10/210.188.0000.0087.800.11120.09%
2024/10/1500.000.287.4087.60-0.2115-0.19%
2024/10/1100.000.187.7087.20-0.1115-0.09%
2024/10/0400.000.187.6087.50-0.1119-0.06%
2024/10/010.788.3000.0088.000.71190.59%
2024/09/0400.001.787.2287.10-1.7134-1.26%
2024/09/020.188.8000.0088.300.11330.07%
2024/08/290.288.7000.0088.000.21350.15%
2024/08/280.188.6000.0088.200.11350.04%
2024/08/260.188.6900.0088.800.11380.07%
2024/08/230.491.500.391.7091.600.21380.11%
2024/08/220.391.7000.0091.800.31380.22%
2024/08/16192.0000.0092.3011410.70%
2024/08/1500.002.590.9492.30-2.5140-1.74%
2024/08/0700.00187.0087.10-1139-0.72%
2024/08/0600.00285.6086.90-2140-1.42%
2024/08/050.187.00586.4686.10-5136-3.64%
2024/07/310.188.7900.0088.900.11310.08%
2024/07/290.788.5000.0088.800.71370.47%
2024/07/230.889.0000.0088.300.81380.58%
2024/07/22188.1000.0088.1011400.71%
2024/07/1600.001.689.5889.90-1.6143-1.13%
2024/07/110.289.6200.0089.300.21700.13%
2024/07/100.589.8200.0089.500.51780.25%
2024/07/090.189.8000.0089.400.11840.03%
2024/07/040.190.40290.2090.20-1.9198-0.96%
2024/06/17090.4000.0090.4002280.01%
2024/06/13189.7000.0089.7012320.43%
2024/06/11190.1000.0090.0012410.41%
2024/06/06089.8000.0089.7002520.01%
2024/06/0500.000.289.9089.90-0.2268-0.07%
2024/06/0400.00189.5089.40-1273-0.37%
2024/06/0300.00189.2089.20-1276-0.36%
2024/05/24189.8000.0090.0012990.33%
2024/05/23190.10190.2090.0003000.00%
2024/05/16390.33190.7090.4023000.67%
2024/05/15190.50190.8090.9002980.00%
2024/04/2300.000.192.0092.60-0.1285-0.04%
2024/04/191.289.7900.0090.001.22800.41%
2024/04/180.194.900.294.8094.60-0.1266-0.04%
2024/04/161.194.03593.6094.00-4254-1.55%
2024/04/120.196.5000.0096.300.12390.04%
2024/04/11194.4000.0095.0012370.42%
2024/04/100.195.900.496.3295.40-0.3230-0.11%
2024/04/090.196.600.396.7096.30-0.2226-0.08%
2024/04/080.697.5000.0097.100.62240.27%
佳醫整併血液透析通路效益顯 下半年營運拚成長Anue鉅亨-2022/09/28
〈佳醫法說〉東南亞市場將調整產品結構 2-3年後可望發酵Anue鉅亨-2020/09/24
佳醫 相關文章
佳醫 相關影音
 
 
25小時3